Skip to Content
Merck
All Photos(2)

Key Documents

Safety Information

911267

Sigma-Aldrich

mPEG24-Hydrazide

Synonym(s):

Methoxy-PEG-HZ, mPEG-Hydrazide

Sign Into View Organizational & Contract Pricing

Select a Size

500 MG
¥49,000

¥49,000


Check Cart for Availability

Request a Bulk Order

Select a Size

Change View
500 MG
¥49,000

About This Item

Empirical Formula (Hill Notation):
C52H106N2O26
Molecular Weight:
1175.40
UNSPSC Code:
12352125
NACRES:
NA.23

¥49,000


Check Cart for Availability

Request a Bulk Order

form

solid

mol wt

average Mn 1200 (by NMR)

reaction suitability

reagent type: chemical modification reagent
reactivity: carboxyl reactive

color

white to off-white

Ω-end

hydrazide

α-end

methoxy

polymer architecture

shape: linear
functionality: monofunctional

storage temp.

−20°C

Application

Polyethylene glycols (PEGs) are FDA approved hydrophilic polymers. They are non-toxic, non-immunogenic and non-antigenic, and are widely used in a varity of biomedical applications such as bioconjugation, drug delivery, surface functionalization, and tissue engineering. Methoxy PEG Hydrazide reacts with aldehydes and ketones to give stable hydrazones in a single step; it can also react with activated carboxylic acids.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

911267-500MG:
911267-BULK:
911267-VAR:


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service